297 related articles for article (PubMed ID: 21940782)
1. FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
Kim DH; Perdomo G; Zhang T; Slusher S; Lee S; Phillips BE; Fan Y; Giannoukakis N; Gramignoli R; Strom S; Ringquist S; Dong HH
Diabetes; 2011 Nov; 60(11):2763-74. PubMed ID: 21940782
[TBL] [Abstract][Full Text] [Related]
2. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
[TBL] [Abstract][Full Text] [Related]
3. FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.
Kim DH; Zhang T; Lee S; Calabuig-Navarro V; Yamauchi J; Piccirillo A; Fan Y; Uppala R; Goetzman E; Dong HH
Endocrinology; 2014 Apr; 155(4):1255-67. PubMed ID: 24437489
[TBL] [Abstract][Full Text] [Related]
4. FoxO6 in glucose metabolism (FoxO6).
Kim DH; Zhang T; Lee S; Dong HH
J Diabetes; 2013 Sep; 5(3):233-40. PubMed ID: 23324123
[TBL] [Abstract][Full Text] [Related]
5. FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice.
Kim DH; Lee B; Lee J; Kim ME; Lee JS; Chung JH; Yu BP; Dong HH; Chung HY
Redox Biol; 2019 Jun; 24():101184. PubMed ID: 30974318
[TBL] [Abstract][Full Text] [Related]
6. FoxO integration of insulin signaling with glucose and lipid metabolism.
Lee S; Dong HH
J Endocrinol; 2017 May; 233(2):R67-R79. PubMed ID: 28213398
[TBL] [Abstract][Full Text] [Related]
7. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
8. FoxO1 links hepatic insulin action to endoplasmic reticulum stress.
Kamagate A; Kim DH; Zhang T; Slusher S; Gramignoli R; Strom SC; Bertera S; Ringquist S; Dong HH
Endocrinology; 2010 Aug; 151(8):3521-35. PubMed ID: 20501674
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-phosphorylated DNER sensitizes insulin signaling in hepatic gluconeogenesis by inducing proteasomal degradation of TRB3.
Li J; Huang Y; Yang X; Cai Y; Wang Y; Dai W; Jiang L; Wang C; Wen Z
Mol Metab; 2024 May; 83():101927. PubMed ID: 38553003
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
13. PKB/Akt phosphorylation of ERRγ contributes to insulin-mediated inhibition of hepatic gluconeogenesis.
Kim DK; Kim YH; Hynx D; Wang Y; Yang KJ; Ryu D; Kim KS; Yoo EK; Kim JS; Koo SH; Lee IK; Chae HZ; Park J; Lee CH; Biddinger SB; Hemmings BA; Choi HS
Diabetologia; 2014 Dec; 57(12):2576-85. PubMed ID: 25205222
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
15. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
[TBL] [Abstract][Full Text] [Related]
18. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.
Qin Y; Chen M; Yang Y; Zhou XR; Shao SY; Wang DW; Yuan G
Mol Med Rep; 2018 May; 17(5):7372-7380. PubMed ID: 29568881
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
